How Muscle Stem Cells Repair and Regenerate
Regulation of Muscle Stem Cell Number via Paracrine Signaling
This research explores how our bodies manage the special cells that repair and rebuild muscles after injury or damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11079638 on NIH RePORTER |
What this research studies
Adult muscles have an amazing ability to heal themselves thanks to special cells called satellite cells. These cells can create new muscle fibers or renew themselves to keep a supply of repair cells ready for when you need them. Scientists are still learning how the body controls the number of these important satellite cells, which is key to effective muscle repair. This project is looking into specific signals, like FGF6, and a pathway called Hippo, that seem to increase the number of these muscle repair cells. The goal is to understand these signals better, which could help us find ways to improve muscle healing and regeneration.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but could eventually benefit individuals experiencing muscle damage from athletic injuries, trauma, or age-related muscle weakness.
Not a fit: Patients who do not have conditions related to muscle damage or regeneration would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to help people recover from muscle injuries, diseases, or age-related muscle loss by boosting their natural repair mechanisms.
How similar studies have performed: While the general concept of satellite cells in muscle repair is well-established, the specific regulatory mechanisms involving FGF6 and TEAD1 are being newly explored in this context.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Lepper, Christoph — Ohio State University
- Study coordinator: Lepper, Christoph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.